依那普利联合倍他乐克治疗慢性心衰的临床研究  

Clinical research on enalapril and betaloc in treating chronic heart failure

作　　者：莫伟[1] 许锦荣[2] 凌云[2] 刘衍宇[2] 陈玲[2] 张凌[3] 

机构地区：[1]广东医学院第二附属医院检验科,524003 [2]广东医学院第二附属医院心血管内科,524003 [3]广东医学院第二附属医院特检科,524003

出　　处：《齐齐哈尔医学院学报》2013年第14期2044-2045,共2页Journal of Qiqihar Medical University

基　　金：湛江市科技计划项目(科目代码:2069999)

摘　　要：目的探讨依那普利联合倍他乐克治疗慢性心衰(CHF)的临床效果。方法将我院CHF患者70例随机分为观察组和对照组,对照组给予常规治疗,观察组同时给予依那普利联合倍他乐克治疗,评估两组临床治疗效果。结果观察组患者总有效率明显高于对照组(P<0.05)。治疗后观察组患者EF、LVD、LVFS明显高于对照组(P<0.05)。治疗后观察组患者RDW明显低于对照组(P<0.05)。结论依那普利联合倍他乐克治疗CHF的临床效果明显,值得应用。Objective To investigate the effect of enalapril and betaloc in treating chronic heart failure.Methods The 70 cases with chronic heart failure were divided into the observe group and the control group.The control group received the normal treatment,and at the same time the observe group received the treatment of enalapril and betaloc.Results The total rate of controlling the ventricular arrhythmia in the observe group was more than those in control group（P 0.05）.The EF,LVD and LVFS of improving the heart function in the observe group was superior to those in control group（P 0.05）.The RDW of in the observe group was lower than that in control group（P 0.05）.Conclusions The effect of enalapril and betaloc in treating chronic heart failure in treating chronic heart failure is obvious,so they are worth being used.

关 键 词：依那普利 倍他乐克 慢性心衰 

分 类 号：R544.1[医药卫生—心血管疾病]